Associated Papers
Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.
Madar-Shapiro L et al.
Fetal Diagnosis and Therapy, 2018
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.
Meiri H et al.
Computational and Structural Biotechnology Journal, 2017
A novel exonic variant (221delT) in the LGALS13 gene encoding placental protein 13 (PP13) is associated with preterm labour in a low risk population.
Gebhardt S et al.
Journal of Reproductive Immunology, 2009
Select a paper to view details